{"changeSha256":"ee731a226c09a3e243f4f50ff1930019663fb635769d6dbf2674ac8eefc17718","changedAt":"2026-11-14","changedFields":[{"after":"FDA-approved as Scenesse for erythropoietic protoporphyria","before":"U.S. label record","field":"Status"},{"after":"A melanocortin receptor agonist approved by FDA as Scenesse to increase pain-free light exposure in adults with erythropoietic protoporphyria.","before":"A melanocortin analogue. This profile cites a U.S. label record.","field":"Profile summary"},{"after":"Two smaller randomized, vehicle-controlled trials described in the label found more time in direct sunlight on pain-free days than with the vehicle. The label warns of serious allergic reactions and darkening of skin, moles and freckles.","before":"The cited DailyMed label identifies Afamelanotide and contains the product's official indications and warnings. This profile links to the label without restating it as medical guidance.","field":"Evidence note"},{"after":"dailymed-afamelanotide-94f53286-11dd-7fbb-e053-2a95a90a7c48-v11, fda-drugs-nda210797-2019-10-08-afc1f17d523d","before":"dailymed-afamelanotide-94f53286-11dd-7fbb-e053-2a95a90a7c48-v11","field":"Cited source records"},{"after":"U.S. National Library of Medicine [sources: dailymed-afamelanotide-94f53286-11dd-7fbb-e053-2a95a90a7c48-v11]; U.S. Food and Drug Administration [sources: fda-drugs-nda210797-2019-10-08-afc1f17d523d]","before":"U.S. National Library of Medicine [sources: dailymed-afamelanotide-94f53286-11dd-7fbb-e053-2a95a90a7c48-v11]","field":"Named organizations"},{"after":"name: dailymed-afamelanotide-94f53286-11dd-7fbb-e053-2a95a90a7c48-v11; aliases: dailymed-afamelanotide-94f53286-11dd-7fbb-e053-2a95a90a7c48-v11; category: dailymed-afamelanotide-94f53286-11dd-7fbb-e053-2a95a90a7c48-v11; status: dailymed-afamelanotide-94f53286-11dd-7fbb-e053-2a95a90a7c48-v11, fda-drugs-nda210797-2019-10-08-afc1f17d523d; summary: dailymed-afamelanotide-94f53286-11dd-7fbb-e053-2a95a90a7c48-v11, fda-drugs-nda210797-2019-10-08-afc1f17d523d; evidenceNote: dailymed-afamelanotide-94f53286-11dd-7fbb-e053-2a95a90a7c48-v11","before":"name: dailymed-afamelanotide-94f53286-11dd-7fbb-e053-2a95a90a7c48-v11; aliases: dailymed-afamelanotide-94f53286-11dd-7fbb-e053-2a95a90a7c48-v11; category: dailymed-afamelanotide-94f53286-11dd-7fbb-e053-2a95a90a7c48-v11; status: dailymed-afamelanotide-94f53286-11dd-7fbb-e053-2a95a90a7c48-v11; summary: dailymed-afamelanotide-94f53286-11dd-7fbb-e053-2a95a90a7c48-v11; evidenceNote: dailymed-afamelanotide-94f53286-11dd-7fbb-e053-2a95a90a7c48-v11","field":"Claim citations"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/afamelanotide/versions/3/","version":3},"id":"profile:afamelanotide:v3","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"profile-status-changed","notice":"We added a plain-language reader guide with cited answers, re-checked the Scenesse label, and added the Drugs@FDA approval record.","peptideSlugs":["afamelanotide"],"previousChangeEvent":{"path":"/corrections/v1/profiles/afamelanotide/v2.json","sha256":"3e8ae376701ae9d91fd932c2af4a7a843b2aa92a94db42721321a3a05715b1e1"},"previousVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/afamelanotide/versions/2/","version":2},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"dailymed-afamelanotide-94f53286-11dd-7fbb-e053-2a95a90a7c48-v11","name":"DailyMed · U.S. National Library of Medicine","sourceClass":"A","title":"SCENESSE (afamelanotide) implant · SPL version 11 · published 2026-05-13","url":"https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=94f53286-11dd-7fbb-e053-2a95a90a7c48&version=11","verifiedAt":"2026-07-22"},{"id":"fda-drugs-nda210797-2019-10-08-afc1f17d523d","name":"Drugs@FDA via openFDA","sourceClass":"A","title":"Drugs@FDA application NDA210797 · original submission status AP · 2019-10-08 · dataset 2026-08-13","url":"https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA210797%22&limit=1","verifiedAt":"2026-08-14"}],"subject":{"slug":"afamelanotide","type":"profile"}}
